Research.Patient.info
Alzheimer’s disease dementia research hub
2 indexed studies · 1 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants with Mild to Moderate Alzheimer’s Disease Dementia
This study is testing a new medicine, MK-1167, for people with mild to moderate Alzheimer's disease. Researchers want to see if it helps improve memory and thinking, and if it's safe to use. Some participants will receive the medicine, while others will get a dummy pill.
Netherlands · Italy · Spain - active not recruitingPHASE2
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
This study is looking at a new medicine called BIIB080 for people with early Alzheimer's disease. Researchers want to see if it's safe and if it can slow down memory and thinking problems. They're also comparing different doses to a dummy medicine.
United States · Australia · Belgium